A phase 1 dose escalation study of VS-5584, a PI3K/mTOR inhibitor, administered with VS-6063, a focal adhesion kinase inhibitor, in mesothelioma Meeting Abstract
| Authors: | Banerji, U.; Fennell, D. A.; Kindler, H. L.; Zauderer, M. G.; Keegan, M.; Horobin, J. |
| Abstract Title: | A phase 1 dose escalation study of VS-5584, a PI3K/mTOR inhibitor, administered with VS-6063, a focal adhesion kinase inhibitor, in mesothelioma |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Keywords: | mesothelioma; pi3k; mtor |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S630 |
| Language: | English |
| ACCESSION: | WOS:000370365103098 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30012-0 |
| Notes: | Meeting Abstract: P2.08-008 -- Source: Wos |
